The $125 billion question: how will the ACA affect cancer survivors?
In 2010, the total cost of cancer care in the United States reached $125 billion. Cancer patients are also living longer today, which is further increasing the cost of their continued care. As the health insurance exchanges have opened and heated debate about the Affordable Care Act (ACA) continues, many questions remain, including the $125 billion question: “How will the ACA affect the most expensive disease: cancer?”
Massey researcher awarded grant to further develop a novel therapy for neuroblastoma
VCU Massey Cancer Center researcher Anthony Faber, Ph.D., was awarded a $46,000 grant from the Rally Foundation for Childhood Cancer Research and The Truth 365 to support his research to develop a new therapy for neuroblastoma, a rare type of cancer that develops in infants and young children.
Massey welcomes William McGuire as director of the Phase I Solid Tumor Program
VCU Massey Cancer Center welcomes physician-researcher William McGuire III, M.D., as the director of the Phase 1 Solid Tumor Program. Also a medical oncologist and member of the Developmental Therapeutics research program at Massey, McGuire joined the VCU Department of Internal Medicine in fall 2014 as a professor of medicine in the Division of Hematology, Oncology and Palliative Care. An expert in gynecologic cancers and developmental therapeutics, McGuire was instrumental in the development of paclitaxel as part of the standard of care for advanced ovarian cancer.
Massey researcher part of global scientific task force that found linkages between mixtures of commonly encountered chemicals and the development of cancer
A global scientific task force involving VCU Massey Cancer Center researcher Masoud Manjili, Ph.D., found that combinations of chemicals encountered every day in our air, food and water can lead to the development of cancer. Assembled by an NGO called “Getting to Know Cancer,” the task force consisted of 174 total scientists from prominent institutions in 28 countries who collaborated to tackle longstanding concerns over the linkages between mixtures of commonly encountered chemicals and the development of cancer.
Renowned cell biologist and biochemist Lewis Cantley keynotes Massey’s annual Cancer Research Retreat
It was the Friday before Memorial Day Weekend, but that didn’t stop more than 140 attendees from participating in VCU Massey Cancer Center’s annual Cancer Research Retreat. Similar to past retreats, the morning featured lectures from Massey research members as well as a keynote address by cell biologist and biochemist Lewis Cantley, Ph.D., Margaret and Herman Sokol Professor in Oncology Research and director of the Sandra and Edward Meyer Cancer Center at Weill Cornell Medical College. In the afternoon, more than 60 student researchers and postdoctoral fellows displayed abstracts in the poster session and competed for up to $250 in Excellence in Cancer Research Awards.
Massey partners with OncLive to raise awareness of cancer research and treatment
VCU Massey Cancer Center has formed a strategic partnership with OncLive® to give healthcare professionals and patients direct, timely access to important oncology research and clinical practice news from Massey and more than 30 other leading cancer centers, nursing schools and physician groups around the country via OncLive’s publications.